Background: Acute ischemic stroke (AIS) stands as a primary cause of both mortality and enduring disability. Given its significant impact on public health, efforts are ongoing to improve prognostic instruments and treatment approaches for this illness. In recent years, attention has been drawn towards the exploration of novel indicators of hemoglobin, albumin, lymphocyte, and platelets (HALP) that measure systemic inflammation and nutritional status.
View Article and Find Full Text PDF